Adam Roseman is the founder and CEO of ARC China.

ARC China is a private equity company that focuses on investment and partnerships with domestic Chinese companies that exhibit high potential for growth. ARC China operates out of its offices in Chengdu, Shanghai, Los Angeles and New York.

ARC China’s twenty five member team focuses primarily on activities across various Chinese industries – specifically healthcare, clean-technology, resources and consumer industries.

ARC China is involved in a host of financial and business activities, managing a number of investment funds and maintaining relationships with various financial concerns across the globe who partner with ARC China, investing with ARC to provide resources to a variety of companies in China. ARC’s partners in these efforts include venture capital companies, private equity firms and private investors as well as other financial institutions.